Galmed pharmaceuticals reports first quarter 2022 financial results

Tel aviv, israel , may 17, 2022 /prnewswire/ —galmed pharmaceuticals ltd. (nasdaq: glmd) ("galmed" or the "company"), a clinical-stage biopharmaceutical company for liver, metabolic, fibrosis and inflammatory diseases reports financial results for the three months ended march 31, 2022.
GLMD Ratings Summary
GLMD Quant Ranking